Clinical Study on Safety and Efficacy of HRS-2129 for Acute Gouty Arthritis
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
The study is being conducted to evaluate the safety, and efficacy of HRS-2129 for acute gouty arthritis. To explore the reasonable dosage of HRS-2129 for acute gouty arthritis.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Able and willing to provide a written informed consent
• Subjects requiring Acute gouty arthritis
• Target joint VAS pain score ≥ 50 mm (screening)
Locations
Other Locations
China
The Third Affiliated Hospital of Sun Yat-sen University
RECRUITING
Guangzhou
Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
RECRUITING
Nanjing
Contact Information
Primary
Lei Tang
lei.tang.lt31@hengrui.com
+0518-82342973
Time Frame
Start Date: 2026-08-19
Estimated Completion Date: 2026-11
Participants
Target number of participants: 90
Treatments
Experimental: Treatment group A: HRS-2129 Tablet
Experimental: Treatment group B: HRS-2129 Tablet
Placebo_comparator: Treatment group C: HRS-2129 Tablet Placebo
Sponsors
Leads: Shandong Suncadia Medicine Co., Ltd.